B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $357
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
B. Riley Securities analyst Yuan Zhi maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $325 to $357.
B. Riley Securities analyst Yuan Zhi maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $325 to $357.
